Devine Impex (531585)
Asset PlayScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹13.11 |
| Market Cap | ₹12.93 Cr |
| P/E Ratio | 78.67 |
| ROCE | 0.37% |
| ROE | 0.85% |
| Dividend Yield | 0% |
| Profit Growth | 0% |
| Debt/Equity | — |
| Sales Growth | 0% |
| 52-Week Range | ₹7.38 — ₹13.11 |
| Sector | Commercial Services & Supplies |
| Book Value | ₹16.78 |
Strengths
- Trading at a 22% discount to book value: P/B 0.78, price ₹13.11 versus book value ₹16.78.
- Piotroski F-Score of 7/9 suggests relatively sound fundamentals on historical financials.
- Price is at the top of the 52-week range (₹7.38–₹13.11), indicating recent market re-rating.
- Low absolute market cap of ₹13 Cr leaves room for a small asset unlock opportunity.
Concerns
- Latest quarter shows zero sales and zero net profit; current operations are effectively not generating earnings.
- ROE of 0.85% and ROCE of 0.37% show capital employed is producing negligible returns.
- P/E of 78.67 with 0.00% sales and profit growth means the earnings-based valuation is extremely stretched.
- No dividend and promoter holding N/A make transparency and shareholder returns unclear.
AI Analysis
At first glance, this looks like a Graham cigar butt. Price ₹13.11 versus book value ₹16.78 gives me a rupee of assets for 78 paise. But a cheap price is not enough. Devine Impex is a small trading and distribution company, and trading businesses rarely have durable moats. The numbers confirm my caution: return on equity is just 0.85%, return on capital employed 0.37%. This company earns almost nothing on the assets it has. Latest quarter shows zero sales and zero net profit, and both sales and profit growth are 0.00%. A 78.67 P/E on that earnings power is simply expensive in another form, however low the P/B appears. No dividend, so I receive no cash while I wait. I cannot even assess promoter holding or debt/equity, and unknown incentives plus unknown leverage make an investment less predictable. On the positive side, the Piotroski F-Score of 7/9 is healthy, and the price is at the top of its 52-week range, so there may be some market optimism. But a score based on historical financials cannot compensate for the absence of current revenue and profit. This is an asset play, not a business I can confidently value on earnings. If the company can deploy its book value to generate real sales and returns, or if management unlocks value through dividends, buybacks or asset sales, there may be upside. Until then, the margin of safety is only as real as the underlying assets and the integrity of management. I would put this in the 'too hard' pile, or follow it closely for a clear catalyst.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer